XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated income statements - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Consolidated income statements [Abstract]      
Revenue $ 1,211,749 $ 1,013,260 $ 1,011,452
Other operating income 74,670 99,525 93,774
Employee benefit expenses (78,758) (54,464) (32,246)
Depreciation, amortization, and impairment charges (439,441) (408,604) (310,755)
Other operating expenses (414,330) (276,666) (261,776)
Operating profit 353,890 373,051 500,449
Financial income 2,755 7,052 4,121
Financial expense (361,270) (378,386) (407,990)
Net exchange differences 1,873 (1,351) 2,674
Other financial income/(expense), net 15,750 40,875 (1,153)
Financial expense, net (340,892) (331,810) (402,348)
Share of profit of associates carried under the equity method 12,304 510 7,457
Profit before income tax 25,302 41,751 105,558
Income tax expense (36,220) (24,877) (30,950)
Profit/(loss) for the year (10,918) 16,874 74,608
Profit attributable to non-controlling interests (19,162) (4,906) (12,473)
Profit/(loss) for the year attributable to the Company $ (30,080) $ 11,968 $ 62,135
Weighted average number of ordinary shares outstanding - basic (in shares) 111,008 101,879 101,063
Weighted average number of ordinary shares outstanding - diluted (in shares) 114,523 103,392 101,063
Basic earnings per share (in dollars per share) $ (0.27) $ 0.12 $ 0.61
Diluted earnings per share (in dollars per share) $ (0.26) $ 0.12 $ 0.61